Invention Grant
- Patent Title: Aldosterone synthase inhibitors
- Patent Title (中): 醛固酮合酶抑制剂
-
Application No.: US14389172Application Date: 2013-03-29
-
Publication No.: US09278093B2Publication Date: 2016-03-08
- Inventor: Amjad Ali , Emmanuel Bey , Rolf Hartmann , Quingzhong Hu , Lina Yin
- Applicant: Merck Sharp & Dohme Corp. , ElexoPharm GmbH
- Applicant Address: US NJ Rahway DE Saarbrucken
- Assignee: Merck Sharp & Dohme Corp.,ElexoPharm GmbH
- Current Assignee: Merck Sharp & Dohme Corp.,ElexoPharm GmbH
- Current Assignee Address: US NJ Rahway DE Saarbrucken
- Agent Janet E. Fair; Anna L. Cocuzzo
- International Application: PCT/US2013/034517 WO 20130329
- International Announcement: WO2013/151876 WO 20131010
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K45/06 ; A61K31/4745
Abstract:
This invention relates to tricyclic triazole compounds or their pharmaceutically acceptable salts. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the above-cited compounds or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.
Public/Granted literature
- US20150306091A1 ALDOSTERONE SYNTHASE INHIBITORS Public/Granted day:2015-10-29
Information query
